109 related articles for article (PubMed ID: 38860943)
1. Probiotics and microbial metabolites maintain barrier and neuromuscular functions and clean protein aggregation to delay disease progression in TDP43 mutation mice.
Zhang Y; Xia Y; Sun J
Gut Microbes; 2024; 16(1):2363880. PubMed ID: 38860943
[TBL] [Abstract][Full Text] [Related]
2. Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis.
Zhang Y; Ogbu D; Garrett S; Xia Y; Sun J
Gut Microbes; 2021; 13(1):1996848. PubMed ID: 34812107
[TBL] [Abstract][Full Text] [Related]
3. Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis.
Zhang YG; Wu S; Yi J; Xia Y; Jin D; Zhou J; Sun J
Clin Ther; 2017 Feb; 39(2):322-336. PubMed ID: 28129947
[TBL] [Abstract][Full Text] [Related]
4. Loss of glial fibrillary acidic protein marginally accelerates disease progression in a SOD1(H46R) transgenic mouse model of ALS.
Yoshii Y; Otomo A; Pan L; Ohtsuka M; Hadano S
Neurosci Res; 2011 Jul; 70(3):321-9. PubMed ID: 21453731
[TBL] [Abstract][Full Text] [Related]
5. Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis.
Pokrishevsky E; Grad LI; Yousefi M; Wang J; Mackenzie IR; Cashman NR
PLoS One; 2012; 7(4):e35050. PubMed ID: 22493728
[TBL] [Abstract][Full Text] [Related]
6. Target Metabolites to Slow Down Progression of Amyotrophic Lateral Sclerosis in Mice.
Ogbu D; Zhang Y; Claud K; Xia Y; Sun J
Metabolites; 2022 Dec; 12(12):. PubMed ID: 36557291
[TBL] [Abstract][Full Text] [Related]
7. A nonsense mutation in mouse Tardbp affects TDP43 alternative splicing activity and causes limb-clasping and body tone defects.
Ricketts T; McGoldrick P; Fratta P; de Oliveira HM; Kent R; Phatak V; Brandner S; Blanco G; Greensmith L; Acevedo-Arozena A; Fisher EM
PLoS One; 2014; 9(1):e85962. PubMed ID: 24465814
[TBL] [Abstract][Full Text] [Related]
8. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
9. Complement components are upregulated and correlate with disease progression in the TDP-43
Lee JD; Levin SC; Willis EF; Li R; Woodruff TM; Noakes PG
J Neuroinflammation; 2018 Jun; 15(1):171. PubMed ID: 29859100
[TBL] [Abstract][Full Text] [Related]
10. Absence of Receptor for Advanced Glycation End Product (RAGE) Reduces Inflammation and Extends Survival in the hSOD1
Lee JD; McDonald TS; Fung JNT; Woodruff TM
Mol Neurobiol; 2020 Oct; 57(10):4143-4155. PubMed ID: 32676989
[TBL] [Abstract][Full Text] [Related]
11. GPNMB ameliorates mutant TDP-43-induced motor neuron cell death.
Nagahara Y; Shimazawa M; Ohuchi K; Ito J; Takahashi H; Tsuruma K; Kakita A; Hara H
J Neurosci Res; 2017 Aug; 95(8):1647-1665. PubMed ID: 27935101
[TBL] [Abstract][Full Text] [Related]
12. Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models.
Magrané J; Cortez C; Gan WB; Manfredi G
Hum Mol Genet; 2014 Mar; 23(6):1413-24. PubMed ID: 24154542
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
14. Electroacupuncture activates enteric glial cells and protects the gut barrier in hemorrhaged rats.
Hu S; Zhao ZK; Liu R; Wang HB; Gu CY; Luo HM; Wang H; Du MH; Lv Y; Shi X
World J Gastroenterol; 2015 Feb; 21(5):1468-78. PubMed ID: 25663766
[TBL] [Abstract][Full Text] [Related]
15. Withania somnifera Reverses Transactive Response DNA Binding Protein 43 Proteinopathy in a Mouse Model of Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration.
Dutta K; Patel P; Rahimian R; Phaneuf D; Julien JP
Neurotherapeutics; 2017 Apr; 14(2):447-462. PubMed ID: 27928708
[TBL] [Abstract][Full Text] [Related]
16. Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis.
Shibata N; Kawaguchi-Niida M; Yamamoto T; Toi S; Hirano A; Kobayashi M
Neuropathology; 2008 Aug; 28(4):387-98. PubMed ID: 18312546
[TBL] [Abstract][Full Text] [Related]
17. Potential Role of the Gut Microbiome in ALS: A Systematic Review.
Wright ML; Fournier C; Houser MC; Tansey M; Glass J; Hertzberg VS
Biol Res Nurs; 2018 Oct; 20(5):513-521. PubMed ID: 29925252
[TBL] [Abstract][Full Text] [Related]
18. Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models.
Barmada SJ; Serio A; Arjun A; Bilican B; Daub A; Ando DM; Tsvetkov A; Pleiss M; Li X; Peisach D; Shaw C; Chandran S; Finkbeiner S
Nat Chem Biol; 2014 Aug; 10(8):677-85. PubMed ID: 24974230
[TBL] [Abstract][Full Text] [Related]
19. Expression of insulin-like growth factor-II and leukemia inhibitory factor antibody immunostaining on the ionized calcium-binding adaptor molecule 1-positive microglias in the spinal cord of amyotrophic lateral sclerosis patients.
Kihira T; Suzuki A; Kubo T; Miwa H; Kondo T
Neuropathology; 2007 Jun; 27(3):257-68. PubMed ID: 17645240
[TBL] [Abstract][Full Text] [Related]
20. Expression of the ALS-causing variant hSOD1(G93A) leads to an impaired integrity and altered regulation of claudin-5 expression in an in vitro blood-spinal cord barrier model.
Meister S; Storck SE; Hameister E; Behl C; Weggen S; Clement AM; Pietrzik CU
J Cereb Blood Flow Metab; 2015 Jul; 35(7):1112-21. PubMed ID: 25853911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
